{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T02:08:49Z","timestamp":1789006129782,"version":"build-2803163510"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T00:00:00Z","timestamp":1782432000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T00:00:00Z","timestamp":1788998400000},"content-version":"vor","delay-in-days":76,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003645","name":"National Cancer Center","doi-asserted-by":"publisher","award":["NCC-1710260"],"award-info":[{"award-number":["NCC-1710260"]}],"id":[{"id":"10.13039\/501100003645","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003645","name":"National Cancer Center","doi-asserted-by":"publisher","award":["NCC-2510510"],"award-info":[{"award-number":["NCC-2510510"]}],"id":[{"id":"10.13039\/501100003645","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003645","name":"National Cancer Center","doi-asserted-by":"publisher","award":["NCC-2511600"],"award-info":[{"award-number":["NCC-2511600"]}],"id":[{"id":"10.13039\/501100003645","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Metastasis is a major contributor to poor patient survival in lung adenocarcinoma (LUAD); however, the underlying mechanisms remain incompletely understood. Unlike tumorigenesis-associated mutations, recurrent genetic alterations specifically linked to metastasis have not been identified, suggesting that epigenetic mechanisms may play a key role. In this study, we report that histone H2A variant H2A.J expression is significantly down-regulated in LUAD, and that low H2A.J levels are associated with unfavorable survival outcomes. Functional assays revealed that H2A.J overexpression suppresses cancer cell invasion and metastatic potential by modulating the expression of metastasis-associated genes, including TMEM158. Mechanistically, H2A.J is deposited in the promoter region of TMEM158, where it alters the local chromatin status to suppress transcriptional activity. Taken together, our findings suggest that H2A.J functions as an epigenetic suppressor of metastasis in LUAD and highlights its potential as both a prognostic biomarker and a therapeutic target to metastatic progression.<\/jats:p>","DOI":"10.1038\/s41419-026-09054-9","type":"journal-article","created":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T03:11:19Z","timestamp":1782443479000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Histone variant H2A.J is an epigenetic regulator of metastasis in lung adenocarcinoma"],"prefix":"10.1038","volume":"17","author":[{"given":"Dong-Gun","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun-Young","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hye-Mi","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyungho","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8292-3738","authenticated-orcid":false,"given":"Youn-Jae","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,26]]},"reference":[{"key":"9054_CR1","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-019-2082-3","volume":"10","author":"HE Zhu","year":"2019","unstructured":"Zhu HE, Yin JY, Chen DX, He S, Chen H. Agmatinase promotes the lung adenocarcinoma tumorigenesis by activating the NO-MAPKs-PI3K\/Akt pathway. Cell Death Dis. 2019;10:854.","journal-title":"Cell Death Dis"},{"key":"9054_CR2","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209\u201349.","journal-title":"CA Cancer J Clin"},{"key":"9054_CR3","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/6615575","volume":"2020","author":"X Chen","year":"2020","unstructured":"Chen X, Bu Q, Yan X, Li Y, Yu Q, Zheng H, et al. Genomic mutations of primary and metastatic lung adenocarcinoma in chinese patients. J Oncol. 2020;2020:6615575.","journal-title":"J Oncol"},{"key":"9054_CR4","doi-asserted-by":"publisher","first-page":"e32217","DOI":"10.1097\/MD.0000000000032217","volume":"101","author":"B Wu","year":"2022","unstructured":"Wu B, Chen J, Zhang X, Feng N, Xiang Z, Wei Y, et al. Prognostic factors and survival prediction for patients with metastatic lung adenocarcinoma: a population-based study. Med (Baltim). 2022;101:e32217.","journal-title":"Med (Baltim)"},{"key":"9054_CR5","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1038\/nature23306","volume":"548","author":"DR Robinson","year":"2017","unstructured":"Robinson DR, Wu YM, Lonigro RJ, Vats P, Cobain E, Everett J, et al. Integrative clinical genomics of metastatic cancer. Nature. 2017;548:297\u2013303.","journal-title":"Nature"},{"key":"9054_CR6","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1126\/science.aat7171","volume":"361","author":"JG Reiter","year":"2018","unstructured":"Reiter JG, Makohon-Moore AP, Gerold JM, Heyde A, Attiyeh MA, Kohutek ZA, et al. Minimal functional driver gene heterogeneity among untreated metastases. Science. 2018;361:1033\u20137.","journal-title":"Science"},{"key":"9054_CR7","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1038\/s41586-019-1689-y","volume":"575","author":"P Priestley","year":"2019","unstructured":"Priestley P, Baber J, Lolkema MP, Steeghs N, de Bruijn E, Shale C, et al. Pan-cancer whole-genome analyses of metastatic solid tumours. Nature. 2019;575:210\u20136.","journal-title":"Nature"},{"key":"9054_CR8","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.ccell.2023.03.018","volume":"41","author":"HB Lengel","year":"2023","unstructured":"Lengel HB, Mastrogiacomo B, Connolly JG, Tan KS, Liu Y, Fick CN, et al. Genomic mapping of metastatic organotropism in lung adenocarcinoma. Cancer Cell. 2023;41:70\u2013985.e973.","journal-title":"Cancer Cell"},{"key":"9054_CR9","doi-asserted-by":"crossref","unstructured":"Talbert PB, Henikoff S. Histone variants at a glance. J Cell Sci. 2021;134:jcs244749.","DOI":"10.1242\/jcs.244749"},{"key":"9054_CR10","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1038\/s41580-020-0262-8","volume":"21","author":"S Martire","year":"2020","unstructured":"Martire S, Banaszynski LA. The roles of histone variants in fine-tuning chromatin organization and function. Nat Rev Mol Cell Biol. 2020;21:522\u201341.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"9054_CR11","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.tplants.2015.04.005","volume":"20","author":"T Kawashima","year":"2015","unstructured":"Kawashima T, Lorkovi\u0107 ZJ, Nishihama R, Ishizaki K, Axelsson E, Yelagandula R, et al. Diversification of histone H2A variants during plant evolution. Trends Plant Sci. 2015;20:419\u201325.","journal-title":"Trends Plant Sci"},{"key":"9054_CR12","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s13072-015-0027-3","volume":"8","author":"K Maehara","year":"2015","unstructured":"Maehara K, Harada A, Sato Y, Matsumoto M, Nakayama KI, Kimura H, et al. Tissue-specific expression of histone H3 variants diversified after species separation. Epigenetics Chromatin. 2015;8:35.","journal-title":"Epigenetics Chromatin"},{"key":"9054_CR13","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1146\/annurev-cancerbio-062722-021823","volume":"8","author":"I Simeonova","year":"2024","unstructured":"Simeonova I, Almouzni G. Histone H3 variants in the multiverse of cancer. Annu Rev Cancer Biol. 2024;8:453\u201374.","journal-title":"Annu Rev Cancer Biol"},{"key":"9054_CR14","doi-asserted-by":"publisher","first-page":"364","DOI":"10.4161\/cc.9.2.10465","volume":"9","author":"A Svotelis","year":"2010","unstructured":"Svotelis A, G\u00e9vry N, Grondin G, Gaudreau L. H2A.Z overexpression promotes cellular proliferation of breast cancer cells. Cell Cycle. 2010;9:364\u201370.","journal-title":"Cell Cycle"},{"key":"9054_CR15","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1101\/gr.118919.110","volume":"22","author":"F Vald\u00e9s-Mora","year":"2012","unstructured":"Vald\u00e9s-Mora F, Song JZ, Statham AL, Strbenac D, Robinson MD, Nair SS, et al. Acetylation of H2A. Z is a key epigenetic modification associated with gene deregulation and epigenetic remodeling in cancer. Genome Res. 2012;22:307\u201321.","journal-title":"Genome Res"},{"key":"9054_CR16","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1101\/gad.1787109","volume":"23","author":"N G\u00e9vry","year":"2009","unstructured":"G\u00e9vry N, Hardy S, Jacques P-\u00c9, Laflamme L, Svotelis A, Robert F, et al. Histone H2A. Z is essential for estrogen receptor signaling. Genes Dev. 2009;23:1522\u201333.","journal-title":"Genes Dev"},{"key":"9054_CR17","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.molcel.2015.05.009","volume":"59","author":"C Vardabasso","year":"2015","unstructured":"Vardabasso C, Gaspar-Maia A, Hasson D, P\u00fcnzeler S, Valle-Garcia D, Straub T, et al. Histone variant H2A. Z. 2 mediates proliferation and drug sensitivity of malignant melanoma. Mol Cell. 2015;59:75\u201388.","journal-title":"Mol Cell"},{"key":"9054_CR18","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1038\/nature09590","volume":"468","author":"A Kapoor","year":"2010","unstructured":"Kapoor A, Goldberg MS, Cumberland LK, Ratnakumar K, Segura MF, Emanuel PO, et al. The histone variant macroH2A suppresses melanoma progression through regulation of CDK8. Nature. 2010;468:1105\u20139.","journal-title":"Nature"},{"key":"9054_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms12914","volume":"7","author":"SM Park","year":"2016","unstructured":"Park SM, Choi EY, Bae M, Kim S, Park JB, Yoo H, et al. Histone variant H3F3A promotes lung cancer cell migration through intronic regulation. Nat Commun. 2016;7:12914.","journal-title":"Nat Commun"},{"key":"9054_CR20","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1093\/jb\/mvz109","volume":"167","author":"H Tanaka","year":"2020","unstructured":"Tanaka H, Sato S, Koyama M, Kujirai T, Kurumizaka H. Biochemical and structural analyses of the nucleosome containing human histone H2A. J J Biochem. 2020;167:419\u201327.","journal-title":"J J Biochem"},{"key":"9054_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms14995","volume":"8","author":"K Contrepois","year":"2017","unstructured":"Contrepois K, Coudereau C, Benayoun BA, Schuler N, Roux PF, Bischof O, et al. Histone variant H2A.J accumulates in senescent cells and promotes inflammatory gene expression. Nat Commun. 2017;8:14995.","journal-title":"Nat Commun"},{"key":"9054_CR22","doi-asserted-by":"publisher","first-page":"2249","DOI":"10.1038\/sj.bjc.6602612","volume":"92","author":"N De Wit","year":"2005","unstructured":"De Wit N, Rijntjes J, Diepstra J, Van Kuppevelt T, Weidle U, Ruiter D, et al. Analysis of differential gene expression in human melanocytic tumour lesions by custom made oligonucleotide arrays. Br J Cancer. 2005;92:2249\u201361.","journal-title":"Br J Cancer"},{"key":"9054_CR23","doi-asserted-by":"publisher","first-page":"10351","DOI":"10.1002\/jcb.28319","volume":"120","author":"X Wang","year":"2019","unstructured":"Wang X, Ghareeb WM, Lu X, Huang Y, Huang S, Chi P. Coexpression network analysis linked H2AFJ to chemoradiation resistance in colorectal cancer. J Cell Biochem. 2019;120:10351\u201362.","journal-title":"J Cell Biochem"},{"key":"9054_CR24","doi-asserted-by":"publisher","first-page":"4065","DOI":"10.1158\/0008-5472.CAN-05-4083","volume":"66","author":"J Yao","year":"2006","unstructured":"Yao J, Weremowicz S, Feng B, Gentleman RC, Marks JR, Gelman R, et al. Combined cDNA array comparative genomic hybridization and serial analysis of gene expression analysis of breast tumor progression. Cancer Res. 2006;66:4065\u201378.","journal-title":"Cancer Res"},{"key":"9054_CR25","doi-asserted-by":"publisher","first-page":"6319","DOI":"10.3934\/mbe.2019315","volume":"16","author":"J Liu","year":"2019","unstructured":"Liu J, Qiu W, Shen X, Sun G. Bioinformatics analysis revealed hub genes and pathways involved in sorafenib resistance in hepatocellular carcinoma. Math Biosci Eng: MBE. 2019;16:6319\u201334.","journal-title":"Math Biosci Eng: MBE"},{"key":"9054_CR26","doi-asserted-by":"publisher","first-page":"98","DOI":"10.3390\/cancers12010098","volume":"12","author":"H-H Lee","year":"2020","unstructured":"Lee H-H, Lin C-H, Lin H-Y, Kuei C-H, Zheng J-Q, Wang Y-H, et al. Histone 2A family member j drives mesenchymal transition and temozolomide resistance in glioblastoma multiforme. Cancers. 2020;12:98.","journal-title":"Cancers"},{"key":"9054_CR27","doi-asserted-by":"publisher","first-page":"W160","DOI":"10.1093\/nar\/gkw257","volume":"44","author":"F Ram\u00edrez","year":"2016","unstructured":"Ram\u00edrez F, Ryan DP, Gr\u00fcning B, Bhardwaj V, Kilpert F, Richter AS, et al. deepTools2: a next generation web server for deep-sequencing data analysis. Nucleic Acids Res. 2016;44:W160\u2013W165.","journal-title":"Nucleic Acids Res"},{"key":"9054_CR28","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-15-182","volume":"15","author":"H Jiang","year":"2014","unstructured":"Jiang H, Lei R, Ding S-W, Zhu S. Skewer: a fast and accurate adapter trimmer for next-generation sequencing paired-end reads. BMC Bioinforma. 2014;15:182.","journal-title":"BMC Bioinforma"},{"key":"9054_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2164-14-774","volume":"14","author":"W Guo","year":"2013","unstructured":"Guo W, Fiziev P, Yan W, Cokus S, Sun X, Zhang MQ, et al. BS-Seeker2: a versatile aligning pipeline for bisulfite sequencing data. BMC Genomics. 2013;14:774.","journal-title":"BMC Genomics"},{"key":"9054_CR30","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1038\/nmeth.1906","volume":"9","author":"J Ernst","year":"2012","unstructured":"Ernst J, Kellis M. ChromHMM: automating chromatin-state discovery and characterization. Nat Methods. 2012;9:215\u20136.","journal-title":"Nat Methods"},{"key":"9054_CR31","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1093\/bioinformatics\/btq033","volume":"26","author":"AR Quinlan","year":"2010","unstructured":"Quinlan AR, Hall IM. BEDTools: a flexible suite of utilities for comparing genomic features. Bioinformatics. 2010;26:841\u20132.","journal-title":"Bioinformatics"},{"key":"9054_CR32","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1093\/bib\/bbs017","volume":"14","author":"H Thorvaldsd\u00f3ttir","year":"2013","unstructured":"Thorvaldsd\u00f3ttir H, Robinson JT, Mesirov JP. Integrative Genomics Viewer (IGV): high-performance genomics data visualization and exploration. Brief Bioinforma. 2013;14:178\u201392.","journal-title":"Brief Bioinforma"},{"key":"9054_CR33","doi-asserted-by":"crossref","unstructured":"Ahn HM, Choi EY, Kim YJ. GPR87 Promotes metastasis through the AKT-eNOS-NO axis in lung adenocarcinoma. Cancers. 2022;14:19.","DOI":"10.3390\/cancers14010019"},{"key":"9054_CR34","doi-asserted-by":"publisher","first-page":"e3000411","DOI":"10.1371\/journal.pbio.3000411","volume":"18","author":"N Percie du Sert","year":"2020","unstructured":"Percie du Sert N, Ahluwalia A, Alam S, Avey MT, Baker M, Browne WJ, et al. Reporting animal research: Explanation and elaboration for the ARRIVE guidelines 2.0. PLOS Biol. 2020;18:e3000411.","journal-title":"PLOS Biol"},{"key":"9054_CR35","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/nbt.3122","volume":"33","author":"M Pertea","year":"2015","unstructured":"Pertea M, Pertea GM, Antonescu CM, Chang T-C, Mendell JT, Salzberg SL. StringTie enables improved reconstruction of a transcriptome from RNA-seq reads. Nat Biotechnol. 2015;33:290\u20135.","journal-title":"Nat Biotechnol"},{"key":"9054_CR36","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1038\/nprot.2016.095","volume":"11","author":"M Pertea","year":"2016","unstructured":"Pertea M, Kim D, Pertea GM, Leek JT, Salzberg SL. Transcript-level expression analysis of RNA-seq experiments with HISAT, StringTie and Ballgown. Nat Protoc. 2016;11:1650\u201367.","journal-title":"Nat Protoc"},{"key":"9054_CR37","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15:550.","journal-title":"Genome Biol"},{"key":"9054_CR38","doi-asserted-by":"crossref","unstructured":"Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. 2005;102:15545\u201350.","DOI":"10.1073\/pnas.0506580102"},{"key":"9054_CR39","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/nmeth.1923","volume":"9","author":"B Langmead","year":"2012","unstructured":"Langmead B, Salzberg SL. Fast gapped-read alignment with Bowtie 2. Nat methods. 2012;9:357\u20139.","journal-title":"Nat methods"},{"key":"9054_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/gb-2008-9-9-r137","volume":"9","author":"Y Zhang","year":"2008","unstructured":"Zhang Y, Liu T, Meyer CA, Eeckhoute J, Johnson DS, Bernstein BE, et al. Model-based analysis of ChIP-Seq (MACS). Genome Biol. 2008;9:1\u20139.","journal-title":"Genome Biol"},{"key":"9054_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2164-15-284","volume":"15","author":"L Shen","year":"2014","unstructured":"Shen L, Shao N, Liu X, Nestler E. ngs. plot: Quick mining and visualization of next-generation sequencing data by integrating genomic databases. BMC Genomics. 2014;15:1\u201314.","journal-title":"BMC Genomics"},{"key":"9054_CR42","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1128\/MCB.01799-07","volume":"28","author":"SS Palii","year":"2008","unstructured":"Palii SS, Van Emburgh BO, Sankpal UT, Brown KD, Robertson KD. DNA methylation inhibitor 5-Aza-2\u2032-deoxycytidine induces reversible genome-wide DNA damage that is distinctly influenced by DNA methyltransferases 1 and 3B. Mol Cell Biol. 2008;28:752\u201371.","journal-title":"Mol Cell Biol"},{"key":"9054_CR43","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1158\/1535-7163.MCT-09-1048","volume":"9","author":"JC Chuang","year":"2010","unstructured":"Chuang JC, Warner SL, Vollmer D, Vankayalapati H, Redkar S, Bearss DJ, et al. S110, a 5-Aza-2\u2032-deoxycytidine\u2013containing dinucleotide, is an effective DNA methylation inhibitor in vivo and can reduce tumor growth. Mol Cancer Therapeutics. 2010;9:1443\u201350.","journal-title":"Mol Cancer Therapeutics"},{"key":"9054_CR44","doi-asserted-by":"publisher","first-page":"e1007902","DOI":"10.1371\/journal.pgen.1007902","volume":"15","author":"M Rigau","year":"2019","unstructured":"Rigau M, Juan D, Valencia A, Rico D. Intronic CNVs and gene expression variation in human populations. PLOS Genet. 2019;15:e1007902.","journal-title":"PLOS Genet"},{"key":"9054_CR45","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1038\/nsmb.1665","volume":"16","author":"M Buschbeck","year":"2009","unstructured":"Buschbeck M, Uribesalgo I, Wibowo I, Ru\u00e9 P, Martin D, Gutierrez A, et al. The histone variant macroH2A is an epigenetic regulator of key developmental genes. Nat Struct Mol Biol. 2009;16:1074\u20139.","journal-title":"Nat Struct Mol Biol"},{"key":"9054_CR46","doi-asserted-by":"publisher","first-page":"18385","DOI":"10.1073\/pnas.0507975102","volume":"102","author":"B Li","year":"2005","unstructured":"Li B, Pattenden SG, Lee D, Guti\u00e9rrez J, Chen J, Seidel C, et al. Preferential occupancy of histone variant H2AZ at inactive promoters influences local histone modifications and chromatin remodeling. Proc Natl Acad Sci USA. 2005;102:18385\u201390.","journal-title":"Proc Natl Acad Sci USA"},{"key":"9054_CR47","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.semcancer.2019.08.018","volume":"60","author":"S Marx","year":"2020","unstructured":"Marx S, Dal Maso T, Chen JW, Bury M, Wouters J, Michiels C, et al. Transmembrane (TMEM) protein family members: Poorly characterized even if essential for the metastatic process. Semin Cancer Biol. 2020;60:96\u2013106.","journal-title":"Semin Cancer Biol"},{"key":"9054_CR48","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1038\/s41417-021-00414-5","volume":"29","author":"J Li","year":"2022","unstructured":"Li J, Wang X, Chen L, Zhang J, Zhang Y, Ren X, et al. TMEM158 promotes the proliferation and migration of glioma cells via STAT3 signaling in glioblastomas. Cancer Gene Ther. 2022;29:1117\u201329.","journal-title":"Cancer Gene Ther"},{"key":"9054_CR49","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s13046-015-0193-y","volume":"34","author":"Z Cheng","year":"2015","unstructured":"Cheng Z, Guo J, Chen L, Luo N, Yang W, Qu X. Overexpression of TMEM158 contributes to ovarian carcinogenesis. J Exp Clin Cancer Res. 2015;34:75.","journal-title":"J Exp Clin Cancer Res"},{"key":"9054_CR50","doi-asserted-by":"publisher","first-page":"2761","DOI":"10.1002\/jcp.29181","volume":"235","author":"Y Fu","year":"2020","unstructured":"Fu Y, Yao N, Ding D, Zhang X, Liu H, Ma L, et al. TMEM158 promotes pancreatic cancer aggressiveness by activation of TGF\u03b21 and PI3K\/AKT signaling pathway. J Cell Physiol. 2020;235:2761\u201375.","journal-title":"J Cell Physiol"},{"key":"9054_CR51","doi-asserted-by":"crossref","unstructured":"Chen P, Yang J, Jin S, Li Y, Li D, Zhong C, et al. TMEM158 promotes ICC metastasis via inducing lactic acid mediated reduction of actin skeleton stiffness of ICC cells. J Adv Res. 2026;79:751\u201368.","DOI":"10.1016\/j.jare.2025.04.003"},{"key":"9054_CR52","doi-asserted-by":"publisher","DOI":"10.1186\/s40364-018-0122-2","volume":"6","author":"L Gan","year":"2018","unstructured":"Gan L, Yang Y, Li Q, Feng Y, Liu T, Guo W. Epigenetic regulation of cancer progression by EZH2: from biological insights to therapeutic potential. Biomark Res. 2018;6:10.","journal-title":"Biomark Res"},{"key":"9054_CR53","doi-asserted-by":"crossref","unstructured":"Mangelinck A, Coudereau C, Courbeyrette R, Ourarhni K, Hamiche A, Redon C, et al. The H2A. J histone variant contributes to Interferon-Stimulated Gene expression in senescence by its weak interaction with H1 and the derepression of repeated DNA sequences. bioRxiv: 2020.2010.","DOI":"10.1101\/2020.10.29.361204"},{"key":"9054_CR54","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s00018-013-1343-z","volume":"71","author":"C Vardabasso","year":"2014","unstructured":"Vardabasso C, Hasson D, Ratnakumar K, Chung C-Y, Duarte LF, Bernstein E. Histone variants: emerging players in cancer biology. Cell Mol Lif Sci. 2014;71:379\u2013404.","journal-title":"Cell Mol Lif Sci"},{"key":"9054_CR55","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1038\/ng.409","volume":"41","author":"C Jin","year":"2009","unstructured":"Jin C, Zang C, Wei G, Cui K, Peng W, Zhao K, et al. H3.3\/H2A.Z double variant\u2013containing nucleosomes mark \u2018nucleosome-free regions\u2019 of active promoters and other regulatory regions. Nat Genet. 2009;41:941\u20135.","journal-title":"Nat Genet"},{"key":"9054_CR56","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1038\/s41568-020-00330-0","volume":"21","author":"FG Ghiraldini","year":"2021","unstructured":"Ghiraldini FG, Filipescu D, Bernstein E. Solid tumours hijack the histone variant network. Nat Rev Cancer. 2021;21:257\u201375.","journal-title":"Nat Rev Cancer"},{"key":"9054_CR57","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.tig.2021.10.003","volume":"38","author":"Y Colino-Sanguino","year":"2022","unstructured":"Colino-Sanguino Y, Clark SJ, Valdes-Mora F. The H2A.Z-nucleosome code in mammals: emerging functions. Trends Genet. 2022;38:273\u201389.","journal-title":"Trends Genet"},{"key":"9054_CR58","doi-asserted-by":"publisher","first-page":"e1003778","DOI":"10.1371\/journal.pgen.1003778","volume":"9","author":"X Chai","year":"2013","unstructured":"Chai X, Nagarajan S, Kim K, Lee K, Choi JK. Regulation of the boundaries of accessible chromatin. PLOS Genet. 2013;9:e1003778.","journal-title":"PLOS Genet"},{"key":"9054_CR59","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1242\/jcs.199216","volume":"130","author":"J Douet","year":"2017","unstructured":"Douet J, Corujo D, Malinverni R, Renauld J, Sansoni V, Posavec Marjanovi\u0107 M, et al. MacroH2A histone variants maintain nuclear organization and heterochromatin architecture. J Cell Sci. 2017;130:1570\u201382.","journal-title":"J Cell Sci"},{"key":"9054_CR60","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1101\/gad.1876110","volume":"24","author":"MJ Gamble","year":"2010","unstructured":"Gamble MJ, Frizzell KM, Yang C, Krishnakumar R, Kraus WL. The histone variant macroH2A1 marks repressed autosomal chromatin, but protects a subset of its target genes from silencing. Genes Dev. 2010;24:21\u201332.","journal-title":"Genes Dev"},{"key":"9054_CR61","doi-asserted-by":"crossref","unstructured":"Yang HD, Kim PJ, Eun JW, Shen Q, Kim HS, Shin WC, et al. Oncogenic potential of histone-variant H2A.Z.1 and its regulatory role in cell cycle and epithelial-mesenchymal transition in liver cancer. Oncotarget 2016;7:11412\u201323.","DOI":"10.18632\/oncotarget.7194"},{"key":"9054_CR62","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1038\/s42003-023-04571-1","volume":"6","author":"W Mohammed Ismail","year":"2023","unstructured":"Mohammed Ismail W, Mazzone A, Ghiraldini FG, Kaur J, Bains M, Munankarmy A, et al. MacroH2A histone variants modulate enhancer activity to repress oncogenic programs and cellular reprogramming. Commun Biol. 2023;6:215.","journal-title":"Commun Biol"},{"key":"9054_CR63","doi-asserted-by":"publisher","first-page":"2437","DOI":"10.1128\/MCB.01315-13","volume":"34","author":"KM Hussey","year":"2014","unstructured":"Hussey KM, Chen H, Yang C, Park E, Hah N, Erdjument-Bromage H, et al. The histone variant MacroH2A1 regulates target gene expression in part by recruiting the transcriptional coregulator PELP1. Mol Cell Biol. 2014;34:2437\u201349.","journal-title":"Mol Cell Biol"},{"key":"9054_CR64","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.gde.2015.12.002","volume":"37","author":"L-M Zink","year":"2016","unstructured":"Zink L-M, Hake SB. Histone variants: nuclear function and disease. Curr Opin Genet Dev Cell. 2016;37:82\u201389.","journal-title":"Curr Opin Genet Dev Cell"},{"key":"9054_CR65","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abo0876","volume":"8","author":"D Sun","year":"2022","unstructured":"Sun D, Singh DK, Carcamo S, Filipescu D, Khalil B, Huang X, et al. MacroH2A impedes metastatic growth by enforcing a discrete dormancy program in disseminated cancer cells. Sci Adv. 2022;8:eabo0876.","journal-title":"Sci Adv"},{"key":"9054_CR66","doi-asserted-by":"publisher","first-page":"4244","DOI":"10.1128\/MCB.05244-11","volume":"31","author":"L Novikov","year":"2011","unstructured":"Novikov L, Park JW, Chen H, Klerman H, Jalloh AS, Gamble MJ. QKI-mediated alternative splicing of the histone variant MacroH2A1 regulates cancer cell proliferation. Mol Cell Biol. 2011;31:4244\u201355.","journal-title":"Mol Cell Biol"},{"key":"9054_CR67","doi-asserted-by":"publisher","first-page":"3423","DOI":"10.1038\/onc.2009.26","volume":"28","author":"JC Sporn","year":"2009","unstructured":"Sporn JC, Kustatscher G, Hothorn T, Collado M, Serrano M, Muley T, et al. Histone macroH2A isoforms predict the risk of lung cancer recurrence. Oncogene. 2009;28:3423\u20138.","journal-title":"Oncogene"},{"key":"9054_CR68","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.4161\/epi.21975","volume":"7","author":"D Rossetto","year":"2012","unstructured":"Rossetto D, Avvakumov N, C\u00f4t\u00e9 J. Histone phosphorylation: a chromatin modification involved in diverse nuclear events. Epigenetics. 2012;7:1098\u2013108.","journal-title":"Epigenetics"},{"key":"9054_CR69","doi-asserted-by":"publisher","DOI":"10.1186\/s12915-018-0568-6","volume":"16","author":"Y Wang","year":"2018","unstructured":"Wang Y, Long H, Yu J, Dong L, Wassef M, Zhuo B, et al. Histone variants H2A.Z and H3.3 coordinately regulate PRC2-dependent H3K27me3 deposition and gene expression regulation in mES cells. BMC Biol. 2018;16:107.","journal-title":"BMC Biol"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-09054-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-09054-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-09054-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T01:45:33Z","timestamp":1789004733000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-09054-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,26]]},"references-count":69,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["9054"],"URL":"https:\/\/doi.org\/10.1038\/s41419-026-09054-9","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,26]]},"assertion":[{"value":"8 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"This study was reviewed and approved by the Institutional Animal Care and Use Committee (IACUC) of National Cancer Center Research Institute (Approval # NCC-20-423). NCCRI is an Association for Assessment and Accreditation of Laboratory Animal Care International (AAALAC International) accredited facility and abides by the Institute of Laboratory Resources (ILAR) guide.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"791"}}